Russia's Interfax news agency reported on Thursday that Russian biopharmaceutical company Petrovax has said that 92.5% of Russian volunteers in trials of the Chinese Ad5-Ncov vaccine against COVID-19 had shown high levels of antibodies.
Reportedly, Ad5-nCoV is a candidate vaccine co-developed by Chinese vaccine company CanSino Biologics and a Chinese military-backed research unit.
Russia's Sputnik V COVID-19 vaccine approved in Vietnam
US FDA's vaccine advisers to consider third possible COVID-19 vaccine for US on 26 February 2021
Jordan to accelerate COVID-19 vaccination drive in coming weeks with more doses expected
Canada's COVID-19 vaccination campaign ramps up with arrival of more vaccine doses
Brazil signs contract to purchase 20 million COVID-19 vaccine doses from India's Bharat Biotech
Colombia extends health state of emergency by three months to contain COVID-19 spread